MED10 and bladder transitional cell carcinoma: Bioinformatics-aided analyses of the GPL570 platform [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array (n = 162,085) (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GPL570) revealed that the expression of MED10 transcripts was significantly higher in the BLCA patients than in their normal peers (1.66-fold, p = 0.002) (Figure 1A).